Runtz is a balanced hybrid medical cannabis strain combining the best therapeutic properties of both indica and sativa genetics. With THC at 19-24% and CBD at 0.1%, this EU-GMP certified strain provides versatile relief suitable for multiple medical conditions throughout the day.
Medical Properties
Hybrid strains such as Runtz offer a comprehensive therapeutic profile, addressing both physical symptoms and psychological wellbeing. Patients benefit from moderate relaxation alongside maintained cognitive function, making this strain suitable for conditions including chronic pain, multiple sclerosis, PTSD, and anxiety disorders.
Cultivation and Quality
Cultivated by Nimbus under EU-GMP pharmaceutical conditions, every batch of this strain is produced to the highest standards of medical cannabis manufacturing. Full traceability, consistent cannabinoid profiles, and rigorous quality control ensure predictable, reproducible therapeutic outcomes.
Dosage Guidance
Dosing should be individualised and titrated upward slowly under physician guidance. The balanced cannabinoid profile makes this strain suitable for both novice and experienced medical cannabis patients.
